vs
Side-by-side financial comparison of Autolus Therapeutics plc (AUTL) and Clearfield, Inc. (CLFD). Click either name above to swap in a different company.
Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $21.2M, roughly 1.6× Autolus Therapeutics plc). Clearfield, Inc. runs the higher net margin — -1.8% vs -373.3%, a 371.5% gap on every dollar of revenue. Clearfield, Inc. produced more free cash flow last quarter ($-2.4M vs $-72.3M).
Autolus Therapeutics plc is a clinical-stage biopharmaceutical company specializing in the development of next-generation engineered chimeric antigen receptor T-cell (CAR-T) therapies for the treatment of hematological malignancies and solid tumors. It operates in the global oncology biotech market, advancing a pipeline of targeted immunotherapy candidates across multiple clinical development stages.
Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.
AUTL vs CLFD — Head-to-Head
Income Statement — Q3 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $21.2M | $34.3M |
| Net Profit | $-79.1M | $-614.0K |
| Gross Margin | — | 33.2% |
| Operating Margin | -337.9% | -5.3% |
| Net Margin | -373.3% | -1.8% |
| Revenue YoY | — | -3.2% |
| Net Profit YoY | 3.6% | 67.8% |
| EPS (diluted) | $-0.30 | $-0.04 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $34.3M | ||
| Q3 25 | $21.2M | $23.4M | ||
| Q2 25 | $20.9M | $49.9M | ||
| Q1 25 | $9.0M | $47.2M | ||
| Q4 24 | — | $29.7M | ||
| Q3 24 | $0 | $5.6M | ||
| Q2 24 | $0 | $48.8M | ||
| Q1 24 | $10.1M | $36.9M |
| Q4 25 | — | $-614.0K | ||
| Q3 25 | $-79.1M | $-9.1M | ||
| Q2 25 | $-47.9M | $1.6M | ||
| Q1 25 | $-70.2M | $1.3M | ||
| Q4 24 | — | $-1.9M | ||
| Q3 24 | $-82.1M | — | ||
| Q2 24 | $-58.3M | $-447.0K | ||
| Q1 24 | $-52.7M | $-5.9M |
| Q4 25 | — | 33.2% | ||
| Q3 25 | — | 53.2% | ||
| Q2 25 | — | 30.5% | ||
| Q1 25 | — | 30.1% | ||
| Q4 24 | — | 29.2% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 21.9% | ||
| Q1 24 | — | 7.7% |
| Q4 25 | — | -5.3% | ||
| Q3 25 | -337.9% | 10.3% | ||
| Q2 25 | -292.6% | 3.0% | ||
| Q1 25 | -726.3% | 0.6% | ||
| Q4 24 | — | -6.9% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -4.7% | ||
| Q1 24 | -384.1% | -26.4% |
| Q4 25 | — | -1.8% | ||
| Q3 25 | -373.3% | -38.8% | ||
| Q2 25 | -229.0% | 3.2% | ||
| Q1 25 | -781.1% | 2.8% | ||
| Q4 24 | — | -6.4% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -0.9% | ||
| Q1 24 | -522.1% | -16.0% |
| Q4 25 | — | $-0.04 | ||
| Q3 25 | $-0.30 | $-0.65 | ||
| Q2 25 | $-0.18 | $0.11 | ||
| Q1 25 | $-0.26 | $0.09 | ||
| Q4 24 | — | $-0.13 | ||
| Q3 24 | $-0.31 | — | ||
| Q2 24 | $-0.22 | $-0.04 | ||
| Q1 24 | $-0.24 | $-0.40 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $86.1M | $96.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $265.5M | $249.7M |
| Total Assets | $661.9M | $268.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $96.4M | ||
| Q3 25 | $86.1M | $106.0M | ||
| Q2 25 | $123.8M | $117.2M | ||
| Q1 25 | $95.8M | $112.0M | ||
| Q4 24 | — | $113.0M | ||
| Q3 24 | $657.1M | $129.0M | ||
| Q2 24 | $705.9M | $123.8M | ||
| Q1 24 | $758.5M | $142.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.2M | ||
| Q2 24 | — | $2.1M | ||
| Q1 24 | — | — |
| Q4 25 | — | $249.7M | ||
| Q3 25 | $265.5M | $256.2M | ||
| Q2 25 | $346.5M | $264.5M | ||
| Q1 25 | $371.1M | $265.9M | ||
| Q4 24 | — | $267.4M | ||
| Q3 24 | $477.0M | $275.8M | ||
| Q2 24 | $527.8M | $274.6M | ||
| Q1 24 | $582.0M | $279.2M |
| Q4 25 | — | $268.1M | ||
| Q3 25 | $661.9M | $306.2M | ||
| Q2 25 | $721.0M | $314.7M | ||
| Q1 25 | $746.3M | $310.9M | ||
| Q4 24 | — | $303.2M | ||
| Q3 24 | $827.5M | $315.3M | ||
| Q2 24 | $853.6M | $318.1M | ||
| Q1 24 | $901.4M | $315.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.01× | ||
| Q2 24 | — | 0.01× | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-67.9M | $-1.4M |
| Free Cash FlowOCF − Capex | $-72.3M | $-2.4M |
| FCF MarginFCF / Revenue | -341.2% | -7.1% |
| Capex IntensityCapex / Revenue | 20.8% | 2.9% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-322.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-1.4M | ||
| Q3 25 | $-67.9M | — | ||
| Q2 25 | $-72.8M | $7.9M | ||
| Q1 25 | $-75.6M | $3.0M | ||
| Q4 24 | — | $7.2M | ||
| Q3 24 | $-76.7M | $22.2M | ||
| Q2 24 | $-51.1M | $4.0M | ||
| Q1 24 | $-40.5M | $-5.7M |
| Q4 25 | — | $-2.4M | ||
| Q3 25 | $-72.3M | — | ||
| Q2 25 | $-80.1M | $7.5M | ||
| Q1 25 | $-83.8M | $654.0K | ||
| Q4 24 | — | $5.1M | ||
| Q3 24 | $-86.3M | $18.2M | ||
| Q2 24 | $-51.9M | $2.8M | ||
| Q1 24 | $-41.0M | $-7.7M |
| Q4 25 | — | -7.1% | ||
| Q3 25 | -341.2% | — | ||
| Q2 25 | -382.6% | 15.1% | ||
| Q1 25 | -933.1% | 1.4% | ||
| Q4 24 | — | 17.1% | ||
| Q3 24 | — | 323.0% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | -406.8% | -20.8% |
| Q4 25 | — | 2.9% | ||
| Q3 25 | 20.8% | 2.0% | ||
| Q2 25 | 34.8% | 0.8% | ||
| Q1 25 | 91.8% | 5.1% | ||
| Q4 24 | — | 7.0% | ||
| Q3 24 | — | 71.4% | ||
| Q2 24 | — | 2.5% | ||
| Q1 24 | 5.3% | 5.3% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 4.93× | ||
| Q1 25 | — | 2.30× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
